Metraipolis › archive › dc_2bd2d2ddad88

Perinatal Outcomes After the Use of Kampo Medicines Containing Ephedra During Pregnancy — Europe PMC PMID:41184969

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41184969
DOI
10.1002/pds.70251
License (as archived)
solo-consultazione
Archived
2026-11-08T20:37:43.212Z
SHA-256 of the archived text
008772679dff14f062ad6f51effdc83550d89952a17a478a850f87b4d96e00bf
Stable URL of this page
https://metraipolis.com/documento/dc_2bd2d2ddad88

How to cite

Perinatal Outcomes After the Use of Kampo Medicines Containing Ephedra During Pregnancy — Europe PMC PMID:41184969 — Europe PMC (en), https://europepmc.org/article/MED/41184969 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2bd2d2ddad88 (Metraipolis archive dc_2bd2d2ddad88, sha256 008772679dff14f062ad6f51effdc83550d89952a17a478a850f87b4d96e00bf)
BibTeX
@misc{dc2bd2d2ddad88,
  title = {Perinatal Outcomes After the Use of Kampo Medicines Containing Ephedra During Pregnancy — Europe PMC PMID:41184969},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41184969},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2bd2d2ddad88; sha256 008772679dff14f062ad6f51effdc83550d89952a17a478a850f87b4d96e00bf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41184969. Agents can read the archived copy with the MCP tool read_document.